Access cutting-edge eosinophilic esophagitis treatment through this clinical trial at a research site in Chapel Hill. Study-provided care at no cost to qualified participants.
Access eosinophilic esophagitis specialists in Chapel Hill at no cost
This study follows strict safety protocols and ethical guidelines
All study-related eosinophilic esophagitis treatment provided free
The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clinico-pathological remission in adult patients with active eosinophilic esophagitis.
Sponsor: Dr. Falk Pharma GmbH
Check if you qualify for this eosinophilic esophagitis clinical trial in Chapel Hill, NC
If you're searching for eosinophilic esophagitis treatment options in Chapel Hill, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chapel Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced eosinophilic esophagitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.